Literature DB >> 26878804

Bladder cancer: Active surveillance for low-grade Ta bladder tumours.

Mark S Soloway1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26878804     DOI： 10.1038/nrurol.2016.35

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  10 in total

1.  Impact of 2004 ISUP/WHO classification on bladder cancer grading.

Authors:  Soum D Lokeshwar; Roberto Ruiz-Cordero; Marie C Hupe; Merce Jorda; Mark S Soloway
Journal:  World J Urol       Date:  2015-04-02       Impact factor: 4.226

2.  It is time to abandon the "superficial" in bladder cancer.

Authors:  Mark S Soloway
Journal:  Eur Urol       Date:  2007-07-17       Impact factor: 20.096

3.  Watchful waiting policy in recurrent Ta G1 bladder tumors.

Authors:  Ofer N Gofrit; Dov Pode; Adi Lazar; Ran Katz; Amos Shapiro
Journal:  Eur Urol       Date:  2006-01-06       Impact factor: 20.096

4.  Long-term oncological outcomes of an active surveillance program in recurrent low grade Ta bladder cancer.

Authors:  Virginia Hernández; Carlos Llorente; Enrique de la Peña; Elia Pérez-Fernández; Ana Guijarro; Ignacio Sola
Journal:  Urol Oncol       Date:  2015-12-10       Impact factor: 3.498

5.  De novo muscle invasive bladder cancer: is there a change in trend?

Authors:  A Vaidya; M S Soloway; C Hawke; R Tiguert; F Civantos
Journal:  J Urol       Date:  2001-01       Impact factor: 7.450

Review 6.  Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer.

Authors:  Mahul B Amin; Steven C Smith; Victor E Reuter; Jonathan I Epstein; David J Grignon; Donna E Hansel; Oscar Lin; Jesse K McKenney; Rodolfo Montironi; Gladell P Paner; Hikmat A Al-Ahmadie; Ferran Algaba; Syed Ali; Isabel Alvarado-Cabrero; Lukas Bubendorf; Liang Cheng; John C Cheville; Glen Kristiansen; Richard J Cote; Brett Delahunt; John N Eble; Elizabeth M Genega; Christian Gulmann; Arndt Hartmann; Cord Langner; Antonio Lopez-Beltran; Cristina Magi-Galluzzi; Jorda Merce; George J Netto; Esther Oliva; Priya Rao; Jae Y Ro; John R Srigley; Satish K Tickoo; Toyonori Tsuzuki; Saleem A Umar; Theo Van der Kwast; Robert H Young; Mark S Soloway
Journal:  Mod Pathol       Date:  2014-11-21       Impact factor: 7.842

7.  Conservative management of low risk superficial bladder tumors.

Authors:  Raj S Pruthi; Nathan Baldwin; Vishal Bhalani; Eric M Wallen
Journal:  J Urol       Date:  2007-11-12       Impact factor: 7.450

8.  Expectant management of small, recurrent, noninvasive papillary bladder tumors.

Authors:  Mark S Soloway; Darren S Bruck; Sandy S Kim
Journal:  J Urol       Date:  2003-08       Impact factor: 7.450

9.  Safety of active surveillance program for recurrent nonmuscle-invasive bladder carcinoma.

Authors:  V Hernández; M Alvarez; E de la Peña; N Amaruch; M D Martín; J M de la Morena; V Gómez; C Llorente
Journal:  Urology       Date:  2009-04-18       Impact factor: 2.649

10.  Treated history of noninvasive grade 1 transitional cell carcinoma. The National Bladder Cancer Group.

Authors:  G R Prout; B A Barton; P P Griffin; G H Friedell
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450
  10 in total
  1 in total

Review 1.  Molecular Oncology of Bladder Cancer from Inception to Modern Perspective.

Authors:  Soum D Lokeshwar; Maite Lopez; Semih Sarcan; Karina Aguilar; Daley S Morera; Devin M Shaheen; Bal L Lokeshwar; Vinata B Lokeshwar
Journal:  Cancers (Basel)       Date:  2022-05-24       Impact factor: 6.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.